LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that its representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the world's largest international healthcare and medical technology trade fairs. The company stated that attendance at MEDICA is intended to support its ongoing evaluation of healthcare technologies, strategic industry relationships, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities associated with its developing healthcare technology ecosystem.
Management believes participation in international healthcare industry events may provide opportunities to evaluate emerging technologies, support industry relationship development, and advance the company's long-term digital healthcare infrastructure strategy across Latin America and other developing markets. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America."
The company plans to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, AI-focused healthcare companies, and other industry stakeholders operating throughout Europe, Latin America, and additional international markets. However, the company cautioned that attendance at industry conferences and trade fairs does not guarantee strategic relationships, commercial agreements, financing arrangements, technology integrations, revenue generation, or future operational success.
LataMed AI Corp. is a development-stage digital health and AI technology company focused on building scalable telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The company is advancing a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, healthcare analytics, emergency response integration, pharmaceutical logistics, and broader digital healthcare delivery initiatives. Through telehealth infrastructure development, artificial intelligence-driven healthcare technologies, regulatory progression initiatives, strategic relationships, and operational expansion efforts, LataMed AI Corp. is positioning itself to participate in the ongoing modernization and digital transformation of healthcare delivery systems across emerging markets.
For more information, visit https://latamed.ai, follow the company's official Instagram page at https://www.instagram.com/latamedai, or review the company's filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.
